When it comes to finding shares of great companies in the S&P/ASX 300 (INDEXASX: XKO), there are a few things I look for:
- High returns on capital – which can be a sign of a competitively advantaged business
- Talented and well-aligned management – I only invest in companies which are run by managers with lots of ‘skin in the game’
- Long-term growth potential
- High amounts of recurring revenue and sales
- No debt — or, at least, a net cash position
3 ASX 300 Shares I’m Watching Closely in 2019
The following companies come close to meeting my initial criteria but are not yet in my portfolio, for reasons I outline.
Appen Ltd (ASX: APX)
Appen is a machine learning company. Although that sounds like ‘another technology buzzword’, it’s already profitable and growing.
Appen allows small tech companies, such as Flamingo AI Ltd (ASX: FGO), and large technology companies, like Google, Facebook, etc., to make their technology smarter. Appen does this by crowdsourcing human feedback.
For example, if an insurer wanted to improve their AI-driven customer service bot created by Flamingo AI they might outsource some testing to Appen, which would ask its thousands of contractors to test the service and provide feedback to improve the algorithms.
I think of Appen more like a HR management company that is riding the machine learning and AI trends.
Citadel Group Ltd (ASX: CGL)
Canberra-based Citadel Group is a small software company that offers its software and services to ‘manage complexity’ (don’t they all). Clients typically include large private companies and Government departments across health and defence.
I’m naturally biased towards software companies like Citadel because their margins, operating leverage and profitability can be unparalleled — if they have the right product and scale appropriately.
There are a few reasons I don’t own Citadel. Firstly, to me, it seems to be more of a roll-up or acquirer of other technology companies. Those types of growth strategies are harder to execute for long periods of time. Second, Citadel has a bit of debt on its balance sheet.
Arguably, those risks are countered by growing sales and high amounts of recurring free cash flow. Nonetheless, it will remain on my watchlist until I can get more comfortable.
a2 Milk Company Ltd (ASX: A2M)
a2 Milk is the true a2-protein dairy products producer and seller in Australia, New Zealand and beyond. While the jury is out on the science behind a2-protein only milk, the likes of a2 and Blackmores Ltd (ASX: BKL) have proven you don’t need much science behind your product to make a great business.
With growth opportunities abroad in China and the USA, a2 Milk Company’s unique product and growth strategy could still be in its infancy. Indeed, despite its shares rising more than 10 times over recent years, there could be more in store for patient shareholders.
However, with China recently passing new e-commerce laws and a new CEO at the helm, I’m happy to wait on the sidelines, for now.
In summary, these three growing companies appear tempting on first glance — who doesn’t like rapidly-rising sales and share prices. However, I’m happy to keep them on my watchlist in 2019, or until I get more conviction in their valuations.
If you want the name of 1 small-cap technology company I own today, keep reading…
After searching through a market with over 2,000 shares, our expert investment analyst has narrowed it down to just 2 of his favourite rapid-growth shares in a FREE report to Rask Media readers.
Over the past five years, these two shares have gone from being 'tiny caps' to being serious contenders for the ASX 200.
Idea #1 is taking on the world, starting with the huge USA market. In a just a few short years the company has snatched market share away from rivals and is on its way to being the market leader.
Idea #2 uses a 'printer and cartridge' type model to get large and established customers: a) using their healthcare industry-leading product, b) paying for it again and again and again... so it's little wonder this company is tipped to grow at a rapid pace in 2019.
Access the free report by clicking here now. Absolutely no credit card or payment details required.
Disclaimer: Any information contained in this article is limited to general financial/investment advice only. The information has not taken into account your specific needs, goals or objectives, so please consider consulting a licenced and trusted adviser before acting on the information. Please read The Rask Group’s Financial Services Guide (FSG) for more information. This article is authorised by Owen Raszkiewicz of The Rask Group, which is a corporate authorised representative No. 1264179 of Strawman Pty Ltd (ACN: 610 908 211) (AFSL: 501 223).